Pharmaceutical Investing Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union
European Medicines Agency validates Oasmia Pharmaceutical AB’s application to add efficacy data to the approved Apealea
Pharmaceutical Investing European CHMP Adopts Positive Opinion for Yescarta (axicabtagene ciloleucel)
Pharmaceutical Investing Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab)
